|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: new opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: a double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kroemer G and Levine B: Autophagic cell
death: the story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suzuki S, Enosawa S, Kakefuda T, Shinomiya
T, Amari M, Naoe S, Hoshino Y and Chiba K: A novel
immunosuppressant, FTY720, with a unique mechanism of action,
induces long-term graft acceptance in rat and dog
allotransplantation. Transplantation. 61:200–205. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki S, Enosawa S, Kakefuda T, Li XK,
Mitsusada M, Takahara S and Amemiya H: Immunosuppressive effect of
a new drug, FTY720, on lymphocyte responses in vitro and cardiac
allograft survival in rats. Transpl Immunol. 4:252–455. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tedesco-Silva H, Mourad G, Kahan BD, Boira
JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B,
Pellet P and Vanrenterghem Y: FTY720, a novel immunomodulator:
efficacy and safety results from the first phase 2A study in de
novo renal transplantation. Transplantation. 77:1826–1833.
2004.PubMed/NCBI
|
|
12
|
Pelletier D and Hafler DA: Fingolimod for
multiple sclerosis. N Engl J Med. 366:339–347. 2012. View Article : Google Scholar
|
|
13
|
Vadas M, Xia P, McCaughan G and Gamble J:
The role of sphingosine kinase 1 in cancer: oncogene or
non-oncogene addiction? Biochim Biophys Acta. 1781:442–447. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang N, Qi Y, Wadham C, Wang L, Warren A,
Di W and Xia P: FTY720 induces necrotic cell death and autophagy in
ovarian cancer cells: a protective role of autophagy. Autophagy.
6:1157–1167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sukocheva O, Wang L, Verrier E, Vadas MA
and Xia P: Restoring endocrine response in breast cancer cells by
inhibition of the sphingosine kinase-1 signaling pathway.
Endocrinology. 150:4484–4492. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chou TC: Theoretical basis, experimental
design, and computerized simulation of synergism and antagonism in
drug combination studies. Pharmacol Rev. 58:621–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang N, Wu ZM, McGowan E, Shi J, Hong ZB,
Ding CW, Xia P and Di W: Arsenic trioxide and cisplatin synergism
increase cytotoxicity in human ovarian cancer cells: therapeutic
potential for ovarian cancer. Cancer Sci. 100:2459–2464. 2009.
View Article : Google Scholar
|
|
19
|
Agarwal R and Kaye SB: Ovarian cancer:
strategies for overcoming resistance to chemotherapy. Nat Rev
Cancer. 3:502–516. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muggia F: Platinum compounds 30 years
after the introduction of cisplatin: implications for the treatment
of ovarian cancer. Gynecol Oncol. 112:275–281. 2009.PubMed/NCBI
|
|
21
|
Seglen PO and Gordon PB: 3-Methyladenine:
specific inhibitor of autophagic/lysosomal protein degradation in
isolated rat hepatocytes. Proc Natl Acad Sci USA. 79:1889–1892.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tassa A, Roux MP, Attaix D and Bechet DM:
Class III phosphoinositide 3-kinase - Beclin1 complex mediates the
amino acid-dependent regulation of autophagy in C2C12 myotubes.
Biochem J. 376:577–586. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alinari L, Mahoney E, Patton J, Zhang X,
Huynh L, Earl CT, Mani R, Mao Y, Yu B, Quinion C, Towns WH, Chen
CS, Goldenberg DM, Blum KA, Byrd JC, Muthusamy N, Praetorius-Ibba M
and Baiocchi RA: FTY720 increases CD74 expression and sensitizes
mantle cell lymphoma cells to milatuzumab-mediated cell death.
Blood. 118:6893–6903. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Romero Rosales K, Singh G, Wu K, Chen J,
Janes MR, Lilly MB, Peralta ER, Siskind LJ, Bennett MJ, Fruman DA
and Edinger AL: Sphingolipid-based drugs selectively kill cancer
cells by down-regulating nutrient transporter proteins. Biochem J.
439:299–311. 2011.PubMed/NCBI
|
|
25
|
Wallington-Beddoe CT, Hewson J, Bradstock
KF and Bendall LJ: FTY720 produces caspase-independent cell death
of acute lymphoblastic leukemia cells. Autophagy. 7:707–715. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K,
Zhang R, Wang H, Yang W and Liu Z: Autophagy induced by FTY720
promotes apoptosis in U266 cells. Eur J Pharm Sci. 45:600–605.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paglin S, Hollister T, Delohery T, Hackett
N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response
of cancer cells to radiation involves autophagy and formation of
acidic vesicles. Cancer Res. 61:439–444. 2001.
|
|
28
|
Kanzawa T, Germano IM, Komata T, Ito H,
Kondo Y and Kondo S: Role of autophagy in temozolomide-induced
cytotoxicity for malignant glioma cells. Cell Death Differ.
11:448–457. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sato K, Tsuchihara K, Fujii S, Sugiyama M,
Goya T, Atomi Y, Ueno T, Ochiai A and Esumi H: Autophagy is
activated in colorectal cancer cells and contributes to the
tolerance to nutrient deprivation. Cancer Res. 67:9677–9684. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amaravadi RK, Yu D, Lum JJ, Bui T,
Christophorou MA, Evan GI, Thomas-Tikhonenko A and Thompson CB:
Autophagy inhibition enhances therapy-induced apoptosis in a
Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Apel A, Herr I, Schwarz H, Rodemann HP and
Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to
radiation therapy. Cancer Res. 68:1485–1494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bellodi C, Lidonnici MR, Hamilton A,
Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi
T, Yacobi R, Van Etten RA, Donato N, Hunter A, Dinsdale D, Tirrò E,
Vigneri P, Nicotera P, Dyer MJ, Holyoake T, Salomoni P and
Calabretta B: Targeting autophagy potentiates tyrosine kinase
inhibitor-induced cell death in Philadelphia chromosome-positive
cells, including primary CML stem cells. J Clin Invest.
119:1109–1123. 2009. View
Article : Google Scholar
|
